Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Irinotecan (DB00762)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01075048ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerTreatment
NCT00989469Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationTreatment
NCT01008475EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerTreatment